PetMed Express, Inc.

$ 1.75 -2.78 %

PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.

CEO: Leslie C. G. Campbell - https://www.1800petmeds.com

Price objectif

$11 528.57 %

Recommandation

Hold

DCF

$ 0.20

Loading data...

PETS vs S&P500

Loading data...

No data available.

Quick ratio

0.58

indicates that the company may have difficulty covering its short-term debts with its readily available assets.

P/E ratio

-0.64

may indicate that the company is undervalued or has poor growth prospects.

EPS

-2.72

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

-146.59 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

-105.82 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

7.80

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.02

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

-1.57

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

-0.04 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
3 indicates worrying financial health
Altman score
0.30 indicates a high risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.41 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.01 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.